Loading…
Loading…
Addus HomeCare Corporation (ADUS) reached a significant support level, and could be a good pick for investors from a technical perspective. Recently, ADUS's 50-day simple moving average broke out above its 200-day moving average; this is known as a "golden cross.
FRISCO, Texas--(BUSINESS WIRE)--Addus HomeCare Corporation (Nasdaq: ADUS) (the “Company”), a provider of home care services, announced today that Heather Dixon, President and Chief Operating Officer, is no longer with the Company. Brad Bickham, former President and Chief Operating Officer at Addus, has agreed to return as Chief Operating Officer on an interim basis, effective immediately, for a period of one year. “On behalf of the Board and the entire company, I want to thank Heather for her d.
Investors interested in Medical - Outpatient and Home Healthcare stocks are likely familiar with Addus HomeCare (ADUS) and Elanco Animal Health Incorporated (ELAN). But which of these two stocks offers value investors a better bang for their buck right now?
Empowered Funds LLC lowered its holdings in Addus HomeCare Corporation (NASDAQ: ADUS) by 62.3% during the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,772 shares of the company's stock after selling 44,155 shares during the period. Empowered Funds LLC owned about
Addus HomeCare Corporation (ADUS) Q2 2026 Earnings Call Transcript
Addus HomeCare NASDAQ: ADUS reported second-quarter 2026 revenue growth of 8% and adjusted earnings-per-share growth of 16.1%, supported by expansion in personal care and hospice services, improved cash generation and ongoing acquisition activity.
The headline numbers for Addus HomeCare (ADUS) give insight into how the company performed in the quarter ended June 2026, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Addus HomeCare (ADUS) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.69 per share. This compares to earnings of $1.49 per share a year ago.